Interactive Investor
>>

Acerus Pharmaceuticals Corp (TSE:ASP) Share Price

ASP

Acerus Pharmaceuticals Corp

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Drug Manufacturers - Specialty & Generic

 / 

- / -
-
- / -
-
-
-

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XTSE

-

Updated: -

Research

News & analysis

Loading...

Times are shown in GMT-4, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company. Principally, it is engaged in the development, manufacture, marketing, and distribution of branded products in men's and women's health. The company markets its product under brand ESTRACE, NATESTO, GYNOFLOR and TEFINA. The ESTRACE brand markets in Canada and is for the symptomatic relief of menopausal symptoms. Its NATESTO is a licensed nasal gel technology for replacement therapy in adult males diagnosed with hypogonadism. GYNOFLOR offers ultra-low dose vaginal estrogen therapy. Its TEFINA brand product is a low-dose nasal testosterone gel treatment in development for female sexual dysfunction.Acerus Pharmaceuticals Corp is Canada-based specialty pharmaceutical company. Principally, it is engaged in the development, manufacture, marketing, and distribution of innovative, branded products in men’s and women’s health.

TSE:ASP

CA00444G1081

CAD

Loading...

Loading Comparison

Latest ASP News